Prof. Chunkang Yang 杨春康
Chief Physician, Professor
Department of Gastrointestinal Tumor Surgery, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Laparoscopic treatment of gastrointestinal tumors, including cancers of the cardia, stomach, colon, rectum, liver, pancreas, and kidney.
Dr. Yang is a Chief Physician and Professor at Fujian Cancer Hospital, holding a PhD in Clinical Surgery. Dr. Yang served as a visiting scholar at Cleveland Clinic, Memorial Sloan Kettering Cancer Center, and St Mark's Hospital. With over 20 years of experience in minimally invasive surgery for gastrointestinal tumors, Dr. Yang focuses on clinical care and research.
Professional roles
- Chair, Colorectal Cancer Committee, Fujian Anti-Cancer Association
- Vice Chair, Gastric Cancer Committee, Fujian Anti-Cancer Association
- Standing Committee Member, Colorectal Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Transanal Endoscopic Microsurgery Professional Committee, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Yang Chunkang). Papers usually list the name as Chunkang Yang or Yang C.
Selected publications
48 papers on PubMed matched by name and affiliation; 21 as first or senior author since 2016. Most recent first- or senior-author papers:
- Appl Biochem Biotechnol, 2026 (senior author): Correction to: Agmatinase Facilitates Gastric Cancer Tumorigenesis Through PI3K/AKT-Mediated Enhancement of Proliferation, Invasion, and Stemness. PubMed 42550372
- Appl Biochem Biotechnol, 2026 (senior author): Agmatinase Facilitates Gastric Cancer Tumorigenesis Through PI3K/AKT-Mediated Enhancement of Proliferation, Invasion, and Stemness. PubMed 42423875
- World J Surg Oncol, 2026 (senior author): Knocking down FAM110A suppresses colon adenocarcinoma progression by inhibiting the Nrf2/HO-1 axis to induce ferroptosis. PubMed 42168991
- J Transl Med, 2026 (senior author): IFITM1-targeted NIR-II fluorescence imaging enables visualisation of colorectal cancer and metastatic lymph nodes. PubMed 41877118
- Front Oncol, 2025 (senior author): Predicting early recurrence of colorectal cancer liver metastases: an integrative approach using radiomics and machine learning. PubMed 41323384
- Biochem Genet, 2025 (senior author): DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway. PubMed 38478147
- Anal Methods, 2025 (senior author): One-pot isothermal CRISPR/Dx system for specific and sensitive detection of microRNA. PubMed 39744795
- Sci Rep, 2025 (senior author): Constructing individualized follow-up strategies for locally advanced esophageal squamous cell carcinoma patients based on dynamic recurrence risk changes. PubMed 39747490
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion